Han Zeng

11PUBLICATIONS

15CO-AUTHORS

Predictive and prognostic markersHaematological tumoursCancer cell biologyMolecular targetsTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jul 11, 2026

TP53 mutation-biased CD8<sup>+</sup> T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma.

|Jun 29, 2026

Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

|May 20, 2026

Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.

|May 15, 2026

Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.

|Dec 10, 2025

Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma.

Lingkai Zhang, Zhaopei Liu, Yawei Ding

|Aug 11, 2025

ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma.

Zhaopei Liu, Lingkai Zhang, Kaifeng Jin

Pageof 2

Frequent Collaborators

11 joint publications

Kaifeng Jin

11 joint publications

Zhaopei Liu

10 joint publications

Jiejie Xu

Zewei Wang

Weijuan Zhang

Yu Zhu

Yuan Chang

Lingkai Zhang

Xiaohe Su

Yawei Ding

Frequent Collaborators

11 joint publications

Kaifeng Jin

11 joint publications

Zhaopei Liu

10 joint publications

Jiejie Xu

9 joint publications

Zewei Wang